REGISTERED NUMBER: 06107341 (England and Wales)

INTEGRATED HEALTH PARTNERS LIMITED

Unaudited Financial Statements

for the Year Ended 31 December 2023

Page

Company Information

1

Balance Sheet

2

to

3

Notes to the Financial Statements

4

to

7

Directors:

G R Caplan

J Crametz

E Kalimtzis

G Magdanurov

U Dempfle

Secretary:

U Dempfle

Registered office:

86-90 Paul Street

London

EC2A 4NE

Registered number:

06107341 (England and Wales)

Accountants:

Cooper Parry Advisory Limited

Sky View

Argosy Road

East Midlands Airport

Derbyshire

DE74 2SA

Fixed assets

Intangible assets

5

744,678

775,377

Tangible assets

6

95,331

144,570

840,009

919,947

Current assets

Stocks

523,911

419,286

Debtors

7

128,465

59,050

Cash at bank

193,989

218,080

846,365

696,416

Creditors

Amounts falling due within one year

8

589,325

405,239

Net current assets

257,040

291,177

Total assets less current liabilities

1,097,049

1,211,124

Creditors

Amounts falling due after more than one year

9

2,705,325

1,559,247

Net liabilities

(1,608,276

)

(348,123

)

Capital and reserves

Called up share capital

27,898

27,898

Share premium

7,208,925

7,208,925

Retained earnings

(8,845,099

)

(7,584,946

)

(1,608,276

)

(348,123

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 November 2025 and were signed on its behalf by:

U Dempfle - Director

1.	Statutory information

Integrated Health Partners Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The

Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

The financial statements include the consolidation of a US branch and the branch's results have been converted into GBP at the month end date using the average method, balance sheet items are converted at the year end date using the year end rate.

3.	Accounting policies

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Sale of goods

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

- the company has transferred the significant risks and rewards of ownership to the buyer;

- the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

- it is probable that the company will receive the consideration due under the transaction; and

- the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on cost

Motor vehicles

-

25% on cost

Computer equipment

-

25% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern

Significant additional investment funding totalling $950,000 (£741,989) was raised post year end which has allowed the company to invest further into its product, team and operations until the company generates profitable revenue or raises further funding for accelerated capital-backed-growth. The directors believe the company has sufficient resources in order to meet its obligations if and when they fall due and it is for this reason they are of the opinion that the financial statements should be prepared on the going concern basis.

4.	Employees and directors

The average number of employees during the year was 5 (2022 - 4 ) .

5.	Intangible fixed assets

Development

costs

£

Cost

At 1 January 2023

1,072,174

Additions

203,716

At 31 December 2023

1,275,890

Amortisation

At 1 January 2023

296,797

Amortisation for year

234,415

At 31 December 2023

531,212

Net book value

At 31 December 2023

744,678

At 31 December 2022

775,377

6.	Tangible fixed assets

Plant and

Motor

Computer

machinery

vehicles

equipment

Totals

£

£

£

£

Cost

At 1 January 2023

305,245

8,475

31,720

345,440

Additions

1,148

-

1,335

2,483

At 31 December 2023

306,393

8,475

33,055

347,923

Depreciation

At 1 January 2023

175,347

1,587

23,936

200,870

Charge for year

43,502

2,116

6,104

51,722

At 31 December 2023

218,849

3,703

30,040

252,592

Net book value

At 31 December 2023

87,544

4,772

3,015

95,331

At 31 December 2022

129,898

6,888

7,784

144,570

7.

Debtors: amounts falling due within one year

2023

2022

£

£

Trade debtors

9,872

2,016

Other debtors

7,190

7,344

VAT

45,247

-

Prepayments

66,156

49,690

128,465

59,050

8.

Creditors: amounts falling due within one year

2023

2022

£

£

Trade creditors

535,366

355,176

Social security and other taxes

8,970

505

Pensions

651

-

VAT

-

3,145

Other creditors

13,626

-

Accrued expenses

30,712

46,413

589,325

405,239

9.

Creditors: amounts falling due after more than one year

2023

2022

£

£

Other loans - 1-2 years

2,705,325

1,559,247

Included within Other loans disclosed above is a balance of £2,705,325 (2022: £1,559,247) relating to a loan facility agreement with Scn Arici Holdings Limited. The loans bear interest at a rate of 12% per annum and are repayable either by cash or equity issue. The maturity date of the loans was 10 May 2024 and this has been extended on a rolling monthly basis since then. Scn Arici Holdings Limited holds fixed and floating charges over all of the company's property and undertaking as a result of the loan agreement.

10.	Post balance sheet events

Research and Development Tax Credit Claim

The Company submitted a claim for R&D tax credits of £206,487 relating to the year ended 31 December 2021. As at 31 December 2023, the claim was under enquiry by HMRC and no part of the disputed amount had been agreed or repaid.

In April 2025, HMRC concluded its review and accepted £192,861 of the claim, with the claim for the remaining £13,626 voluntarily withdrawn by the Company.

As the settlement relates to conditions existing at the balance sheet date, the Company has adjusted these financial statements to reflect the agreed amount. An adjustment of £13,626 has been recognised in the current year income statement.